Collectively, these results indicated that ERβ isoforms differentially modulate the mTOR, NFkB and JAK–STAT pathways in GBM cells, and suggested that ERβ1, but not ERβ5, displayed tumor-suppressing functions in GBMs. This evidence concerns the gene SOAT1 and glioblastoma.